Ovelle Cetomacrogol Cream BP (Formula A)
About this deal
May require occasional specialist input indefinitely and therefore the patient should not be discharged from specialist care On 1st July 2022 NHS Cheshire and Merseyside Integrated Care Board (ICB) became the new statutory body responsible for ensuring health care services are available to meet the reasonable needs of the people of Cheshire & Merseyside. Please note corticosteroids should be prescribed in line with NICE TA 81 - Frequency of application of topical corticosteroids for atopic eczema.
MHRA (2015). Mycophenolate mofetil (CellCept) and mycophenolic acid: risk of hypogammaglobulinaemia and risk of bronchiectasis. If you’ve tried cetomacrogol cream or another therapeutic skin lotion, we encourage you to share your experiences to help other patients. PatientsLikeMe’s unique data-sharing platform allows you to share detailed data about all types of treatments, interventions and lifestyle modifications that have helped you or simply had no effect.
Combinations of products are often used, eg, soap substitutes +/- bath oils, as well as leave-on products. Medicines recommended or initiated by specialists in primary or secondary care. Non-specialist prescribing in primary care may follow according the RAG criteria. In process of being superceded by Amber Recommended, Amber Initiated and Amber Patient Retained.
For use as an emollient: Apply liberally to the affected area and massage well into the skin. Use as often as required or as directed by your pharmacist or doctor The keratolytic effect of salicylic acid facilitates the absorption of topical corticosteroids; however, excessive and prolonged topical use may result in symptoms of salicylism.Associated with antimuscarinic side effects and should be avoided in patients with closed angle glaucoma Amber Initiated. Requires specialist initiation of prescribing. Prescribing to be continued by the specialist until stabilisation of the dose is achieved and the patient has been reviewed. Amber Initiated medicines must meet criteria: Patient safety alert issued December 2014 on risk of death or serious harm from accidental ingestion of potassium permanganate preparations.
NICE TA701 (2021): Crisaborole for treating mild to moderate atopic dermatitis in people 2 years and older (terminated appraisal) Refer to the Department of Dermatology Hyperhidrosis Pathway for information on diagnosis and management of hyperhidrosis. Pan Mersey (2022): ABROCITINIB tablets(Cibinqo®▼), TRALOKINUMAB injection (Adtralza®▼) or UPADACITINIB prolonged-release tablets(Rinvoq®▼) for treating moderate to severe atopic dermatitis To listen to or request a copy of this leaflet in Braille, large print or audio, please call free of charge: 0800 198 5000 (UK only). In women of child-bearing potential, exclude pregnancy up to 3 days before treatment (start treatment on day 2 or 3 of menstrual cycle), every month during treatment (unless there are compelling reasons to indicate that there is no risk of pregnancy), and 5 weeks after stopping treatment—perform pregnancy test in the first 3 days of the menstrual cycle. Women must practise effective contraception for at least 1 month before starting treatment, during treatment, and for at least 1 month after stopping treatment. Women should be advised to use at least 1 method of contraception, but ideally they should use 2 methods of contraception. Oral progestogen-only contraceptives are not considered effective. Barrier methods should not be used alone, but can be used in conjunction with other contraceptive methods. Each prescription for isotretinoin should be limited to a supply of up to 30 days' treatment and dispensed within 7 days of the date stated on the prescription; repeat prescriptions or faxed prescriptions are not acceptable. Women should be advised to discontinue treatment and to seek prompt medical attention if they become pregnant during treatment or within 1 month of stopping treatment.
Cheshire and Merseyside APG (2023): DEUCRAVACITINIB tablets(Sotyktu®▼) for treating moderate to severe plaque psoriasis Calcipotriolis an analogue of vitamin D that affects cell division and differentiation. Calcitriol is an active form of vitamin D. Vitamin D and its analogues are used first-line for the long-term treatment of plaque psoriasis; they do not smell or stain and they may be more acceptable than tar or dithranol products. Of the vitamin D analogues, calcitriol is less likely to irritate. Elidel®) Cream; 30 g, 60 g, 100 g In line with NICE TA 82 - Tacrolimus and pimecrolimus for atopic eczema (see also NICE CG 153 –Psoriasis - off label indication) Topical preparations Leave-on moisturising ointments, creams, and lotions are most effective when applied immediately after bathing, as water that has entered the epidermis remains there, but they can also be applied at other times. Where prescribing and monitoring are required under shared care, it is implicit that the responsibility for both of these tasks rests with the prescriber.
Implicit in any shared care agreement is the understanding that participation is at the discretion of the Primary Care prescriber subject to their clinical confidence. Cream formulation should be used in preference to the aqueous solution as it has a longer shelf-life and is more cost-effectivesolution for injection (Taltz ®) prefilled syringe; prefilled penNo BNFc entry;Paediatrics, seek specialist advice Protopic®) Ointment; 30g, 60g In line with NICE TA 82 - Tacrolimus and pimecrolimus for atopic eczema (see also NICE CG 153 –Psoriasis - off label indication) Topical preparation Preparations containing an antibacterial (section 13.10) should be avoided unless infection is present or is a frequent complication. In the community, acute impetigo on small areas of the skin may be treated by short-term topical application of fusidic acid or mupirocin. They should not be used for longer than 10 days and local microbiology advice should be sought before using it in hospital to avoid the development of resistance.